抗PD-1抑制剂相关小肠结肠炎的CT表现
单中心回顾性研究纳入21例抗PD-1抗体相关小肠结肠炎患者,于2015年1月至2020年4月行CT检查,由两名委员会认证放射科医师独立评估肠壁强化模式、最大肠壁厚度、最大阑尾直径及各肠段受累情况。结论认为全结肠炎、跳跃性病变和阑尾受累常见,结合低级别腹泻、其他伴发免疫相关不良事件及抗PD-1治疗史,CT可能是有用的诊断工具。
要点
- 全结肠炎和同时累及直肠乙状结肠与盲肠的跳跃性病变各见于9例(42.9%)。
- 直肠是最常受累部位(18/21,85.7%),阑尾受累见于11例(52.4%)。
- 最常见的肠壁强化模式为灰色模式,即增厚肠壁呈轻度均匀强化。
关键影像表现/征象
- 全结肠炎见于9例(42.9%),同时累及直肠乙状结肠和盲肠的跳跃性病变也见于9例(42.9%)。
- 直肠是最常受累部位(18/21,85.7%),阑尾受累见于11例(52.4%)。
- 最常见的肠壁强化模式为灰色模式,即增厚肠壁呈轻度均匀强化。
- 受累阑尾最大直径平均为9.6±4.5 mm(范围4.5-18 mm)。
临床应用与阅片要点
- 阅片时注意评估全结肠炎、同时累及直肠乙状结肠与盲肠的跳跃性病变以及阑尾受累等特征性表现。
- 结合低级别腹泻、其他伴发免疫相关不良事件及抗PD-1治疗史,CT可能有助于抗PD-1抗体相关小肠结肠炎的诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Immune checkpoint inhibitors promote the antitumor activity of T cells; however, there is a risk of side effects. The aim of this study was to characterize the computed tomography (CT) findings of one such side effect, anti-programmed cell death-1 antibody-related enterocolitis (αPD-1-EC).
METHODS: This single-institution retrospective study included 21 patients with αPD-1-EC who underwent CT between January 2015 and April 2020. Two board-certified radiologists independently evaluated the CT findings, including the pattern of intestinal wall enhancement, maximum bowel wall thickness, maximum appendiceal diameter, and involvement of enterocolitis in each intestinal segment. Symptoms and their severity were also investigated.
RESULTS: Pancolitis and skip lesions involving both the rectosigmoid colon and the cecum were found in 9 patients each (42.9%). The rectum was the most frequently involved lesion (18/21, 85.7%), and appendiceal involvement was found in 11 patients (52.4%). The most frequent wall enhancement pattern was the gray pattern (i.e., mild homogeneous enhancement of the thickened bowel wall). The mean maximum diameter of the involved appendix was 9.6 ± 4.5 mm (range 4.5-18 mm). Frequent symptoms included diarrhea (21/21), fever (8/21), and abdominal pain (7/21). Other concomitant immune-related adverse events were found in 6 patients.
CONCLUSIONS: Pancolitis, skip lesions, and appendiceal involvement were frequent in patients with αPD-1-EC. When combining these characteristic findings with other clinical findings, such as low-grade diarrhea, other concomitant immune-related adverse events, and anti-PD-1 therapy administration, CT may be a useful diagnostic tool for αPD-1-EC.
引用
- Kurokawa M, Kurokawa R, Hagiwara A, et al. CT imaging findings of anti-PD-1 inhibitor-related enterocolitis. Abdom Radiol (NY). 2021. PMID: 33638055. doi:10.1007/s00261-021-02986-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。